HCPLive Editorial Staff

The American Society for Preventive Cardiology (ASPC) will host their 2022 Congress on CVD Prevention on July 29 - July 31 in Louisville, Kentucky. The scientific sessions for this year’s conference will emphasize inclusiveness and caring for all at risk of cardiovascular disease.

The programs for this year include cutting-edge lectures, debates, and practical applications, as renowned experts and leaders in the field explore the broad spectrum of preventive cardiology. The topics covered will include:

Overcoming barriers in the treatment of diabetes in clinical practice

Satellite events will include a masterclass on imaging techniques to assess global cardiovascular disease and its risk, a luncheon to network with women in preventive cardiology, and a satellite symposium on saving the hearts of women through prevention.

There will additionally be new research presented in the Abstract Hall and other social opportunities, including an Annual 5k Fun Run, during the weekend.

At the completion of the event, individuals should have the knowledge to identify critical factors for success in preventive cardiology, apply principles of diversity, positive culture, and health equity, and understand the rationale for changes in clinical risk assessment guidelines, and more.

The event is designed for an audience of cardiologists, lipidologists, endocrinologists, internists, family practitioners, osteopaths, nurse practitioners, dieticians, and other healthcare professionals involved in prevention.

Interested parties can register for the event 

 or on-site at the Omni Louisville Hotel, level 2, Commonwealth Pre-Function area. Registration hours are on Friday, July 29 11:00am - 6:00pm and Saturday, July 30 7:00am - 12:00pm.

There will be no hybrid or virtual option to attend the event this year.  Find more information 

Articles

The 2022 scientific sessions in Louisville, Kentucky will emphasize inclusiveness and the care for all at risk for cardiovascular disease. 

2022 ASPC Congress on CVD Prevention Live in Louisville, KY from July 29-31

Recently, Jennifer B. Green, MD, Duke Health, led a 4 person panel of Duke doctors on emerging topics in diabetes management.

The June 22 symposium, called Institutional Perspectives in Type 2 Diabetes: Contemporary Approaches to Insulin Treatment, was part of HCPLive's State of the Science program.

Green kicked the program off with a discussion on the role of insulin therapy in contemporary diabetes management. That was followed by a talk about insulin initiation by Andrea D Coviello, MD, Duke Health,

Next, Susan E. Spratt, MD, Duke Health, talked about intensification and modification of insulin therapy. The final segment was about integrating technology into insulin management, led by Hiba Abou Assi, MD, Duke Health.


Videos

Dr. Jennifer Green led a panel in discussing new treatments and topics in diabetes care.

Institutional Perspectives in Type 2 Diabetes: Contemporary Approaches to Insulin Treatment

A group of experts from the University of North Carolina at Chapel Hill have come together to discuss many crucial topics for the treatment of patients with 

 State of the Science Summit called Institutional Perspectives in Gastroenterology: Inflammatory Bowel Disease.

Leading the group was Millie Long, MD, MPH. Joining Long was Kimberly Weaver, MD, Edward Barnes, MD, MPH, and Hans Herfarth, MD, PhD.

The program began with Weaver’s discussion on managing IBD during COVID-19. Weaver’s discussion was followed by Barnes talking about the early use of biologics and Herfarth’s explainer on newly approved and emerging therapies in IBD.

Long closed out the event with a talk about taking a treat to target approach in IBD.

A group of experts discuss new and emerging therapies for IBD.

Institutional Perspectives in Gastroenterology: Inflammatory Bowel Disease

It is an exciting time for researchers looking at new treatments for 

Building on the success of the unapproved fecal microbiota transplantation (FMT) treatment for C difficile infections, several live microbiota therapeutics are currently in development.

State of the Science Summit, entitled Institutional Perspectives in Infectious Diseases: Management of C. Difficile, a group of experts discussed different topics involved in the care of CDI. 

The summit was chaired by Jason Sniffen, DO, FACP, FIDSA, of Advent Health.

Joining Sniffen was Mathieu Millette, PhD, Bio-K+, Kerry Group, Maryam Kashi, DO, Advent Health System, and Stuart Johnson, MD, Veterans Affairs.

The event kicked off with Millette’s discussion on understanding C difficile infections. Following Millette was Sniffen’s discussion on standard of care and Kashi’s talk about emerging treatment options.

Concluding the evening was Johnson’s explainer on clinical trials for C difficile infections.

There are several emerging treatments for C difficile infections.